GBFG
ATNM icon

Gerald Baker Financial Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Gerald Baker Financial Group’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.3K Sell
19,920
-2,771
-12% -$2.81K 0.01% 123
2026
Q2 		$22.2K Hold
22,691
– – 0.01% 126
2026
Q1 		$22.6K Buy
+22,691
New +$27K 0.01% 114

Other funds holding ATNM

IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Gerald Baker Financial Group's ATNM Position: Q3 2026 in Review

Gerald Baker Financial Group reduced its Actinium Pharmaceuticals (ATNM) stake by 12% in Q3 2026, selling an estimated $2.81K and leaving 19,920 shares worth $22.3K. The position accounts for 0.01% of the portfolio, ranked #123.

Gerald Baker Financial Group first reported a position in ATNM in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.6K in Q1 2026. 2 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.

  • Gerald Baker Financial Group held 19,920 shares of Actinium Pharmaceuticals worth $22.3K as of Q3 2026.
  • Gerald Baker Financial Group sold 2,771 Actinium Pharmaceuticals shares in Q3 2026, an estimated $2.81K.
  • Actinium Pharmaceuticals made up 0.01% of Gerald Baker Financial Group's portfolio in Q3 2026, its #123 holding.
  • Gerald Baker Financial Group first reported a position in Actinium Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Gerald Baker Financial Group's Actinium Pharmaceuticals position peaked at $22.6K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.

Based on Gerald Baker Financial Group's 13F filing for Q3 2026, filed 9 Oct 2026.